Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| BRCA2 Protein | 5 | 2020 | 37 | 1.530 |
Why?
|
| Gene Silencing | 3 | 2020 | 143 | 0.770 |
Why?
|
| Peroxiredoxins | 1 | 2020 | 10 | 0.750 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2021 | 73 | 0.740 |
Why?
|
| Breast Neoplasms | 7 | 2020 | 1426 | 0.710 |
Why?
|
| Transcription Factors | 8 | 2012 | 653 | 0.670 |
Why?
|
| Leishmania donovani | 3 | 2005 | 16 | 0.620 |
Why?
|
| MicroRNAs | 2 | 2020 | 386 | 0.530 |
Why?
|
| Trypanosoma brucei brucei | 4 | 2024 | 80 | 0.520 |
Why?
|
| Promoter Regions, Genetic | 7 | 2012 | 484 | 0.490 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2012 | 781 | 0.480 |
Why?
|
| Leishmania major | 2 | 2010 | 22 | 0.370 |
Why?
|
| Leishmania | 2 | 2010 | 17 | 0.370 |
Why?
|
| Macrophages | 3 | 2010 | 431 | 0.350 |
Why?
|
| Protozoan Proteins | 4 | 2024 | 170 | 0.340 |
Why?
|
| DNA Repair | 2 | 2011 | 181 | 0.340 |
Why?
|
| Down-Regulation | 3 | 2010 | 420 | 0.340 |
Why?
|
| Cell Cycle | 1 | 2010 | 309 | 0.330 |
Why?
|
| Protein Transport | 3 | 2020 | 286 | 0.320 |
Why?
|
| RNA, Small Cytoplasmic | 2 | 2010 | 3 | 0.300 |
Why?
|
| Signal Recognition Particle | 2 | 2010 | 6 | 0.300 |
Why?
|
| Ribonuclease H | 1 | 2005 | 11 | 0.280 |
Why?
|
| Leishmaniasis | 1 | 2005 | 6 | 0.270 |
Why?
|
| Cell Nucleus | 3 | 2020 | 351 | 0.250 |
Why?
|
| RNA, Small Interfering | 3 | 2021 | 391 | 0.240 |
Why?
|
| Protein Binding | 5 | 2020 | 913 | 0.230 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2010 | 249 | 0.220 |
Why?
|
| Binding Sites | 3 | 2021 | 597 | 0.210 |
Why?
|
| Chagas Disease | 1 | 2023 | 96 | 0.210 |
Why?
|
| Mitochondria | 1 | 2005 | 454 | 0.210 |
Why?
|
| Trypanosoma cruzi | 1 | 2023 | 144 | 0.200 |
Why?
|
| Protein Stability | 1 | 2021 | 40 | 0.200 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2021 | 54 | 0.200 |
Why?
|
| RNA, Messenger | 5 | 2012 | 1152 | 0.200 |
Why?
|
| RNA, Untranslated | 2 | 2010 | 42 | 0.190 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2021 | 185 | 0.190 |
Why?
|
| Repressor Proteins | 3 | 2008 | 226 | 0.190 |
Why?
|
| Oxidation-Reduction | 2 | 2020 | 407 | 0.180 |
Why?
|
| Molecular Sequence Data | 6 | 2011 | 1490 | 0.180 |
Why?
|
| Gene Knockdown Techniques | 4 | 2018 | 161 | 0.170 |
Why?
|
| Rad51 Recombinase | 2 | 2011 | 6 | 0.170 |
Why?
|
| Humans | 16 | 2023 | 34853 | 0.170 |
Why?
|
| Conserved Sequence | 2 | 2010 | 106 | 0.160 |
Why?
|
| Gene Expression Regulation | 4 | 2021 | 968 | 0.160 |
Why?
|
| Mitochondrial Proteins | 1 | 2018 | 96 | 0.150 |
Why?
|
| Protein Multimerization | 1 | 2018 | 97 | 0.150 |
Why?
|
| Cell Line, Tumor | 8 | 2012 | 2128 | 0.150 |
Why?
|
| RNA | 2 | 2011 | 234 | 0.140 |
Why?
|
| Amino Acid Sequence | 4 | 2008 | 1124 | 0.140 |
Why?
|
| Animals | 9 | 2021 | 14307 | 0.140 |
Why?
|
| Open Reading Frames | 2 | 2005 | 73 | 0.140 |
Why?
|
| Chromatin Assembly and Disassembly | 3 | 2010 | 41 | 0.130 |
Why?
|
| Oxidative Stress | 1 | 2020 | 874 | 0.120 |
Why?
|
| Alcohol Oxidoreductases | 3 | 2008 | 11 | 0.110 |
Why?
|
| Base Sequence | 4 | 2010 | 932 | 0.110 |
Why?
|
| Desmoplakins | 1 | 2012 | 1 | 0.110 |
Why?
|
| Ribonuclease III | 1 | 2011 | 10 | 0.100 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2011 | 11 | 0.100 |
Why?
|
| Alu Elements | 1 | 2011 | 8 | 0.100 |
Why?
|
| Mitochondrial Membranes | 2 | 2024 | 38 | 0.100 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2010 | 10 | 0.100 |
Why?
|
| RNA Polymerase III | 1 | 2010 | 5 | 0.100 |
Why?
|
| Macular Degeneration | 1 | 2011 | 27 | 0.100 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2010 | 18 | 0.100 |
Why?
|
| Cyclin D1 | 1 | 2010 | 42 | 0.100 |
Why?
|
| Ubiquitination | 1 | 2010 | 54 | 0.100 |
Why?
|
| Cell Polarity | 1 | 2010 | 53 | 0.100 |
Why?
|
| Gene Rearrangement | 1 | 2010 | 15 | 0.090 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2011 | 38 | 0.090 |
Why?
|
| Codon | 1 | 2010 | 38 | 0.090 |
Why?
|
| G1 Phase | 1 | 2010 | 32 | 0.090 |
Why?
|
| 5' Untranslated Regions | 1 | 2010 | 14 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 203 | 0.090 |
Why?
|
| Vertebrates | 1 | 2010 | 29 | 0.090 |
Why?
|
| U937 Cells | 2 | 2010 | 27 | 0.090 |
Why?
|
| Introns | 1 | 2010 | 67 | 0.090 |
Why?
|
| Cytosol | 1 | 2010 | 85 | 0.090 |
Why?
|
| Exons | 1 | 2010 | 80 | 0.090 |
Why?
|
| DNA-Binding Proteins | 3 | 2008 | 522 | 0.090 |
Why?
|
| Two-Hybrid System Techniques | 3 | 2018 | 49 | 0.080 |
Why?
|
| Blotting, Northern | 2 | 2005 | 139 | 0.080 |
Why?
|
| Female | 4 | 2020 | 19873 | 0.080 |
Why?
|
| Molecular Weight | 2 | 2005 | 161 | 0.080 |
Why?
|
| Cell Movement | 1 | 2012 | 545 | 0.080 |
Why?
|
| Cloning, Molecular | 2 | 2005 | 310 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 2 | 2005 | 383 | 0.080 |
Why?
|
| Receptors, Calcitriol | 1 | 2008 | 59 | 0.080 |
Why?
|
| Epigenesis, Genetic | 1 | 2009 | 198 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 605 | 0.070 |
Why?
|
| Trans-Splicing | 1 | 2005 | 1 | 0.070 |
Why?
|
| Untranslated Regions | 1 | 2005 | 6 | 0.070 |
Why?
|
| Densitometry | 1 | 2005 | 13 | 0.070 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2005 | 27 | 0.070 |
Why?
|
| Blotting, Southern | 1 | 2005 | 66 | 0.070 |
Why?
|
| DNA, Protozoan | 1 | 2005 | 21 | 0.070 |
Why?
|
| Genes, Protozoan | 1 | 2005 | 18 | 0.070 |
Why?
|
| Protein Sorting Signals | 1 | 2005 | 26 | 0.070 |
Why?
|
| Genetic Complementation Test | 1 | 2005 | 56 | 0.070 |
Why?
|
| Escherichia coli | 2 | 2005 | 436 | 0.070 |
Why?
|
| Alternative Splicing | 1 | 2005 | 82 | 0.070 |
Why?
|
| Gene Dosage | 1 | 2005 | 74 | 0.070 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2005 | 11 | 0.070 |
Why?
|
| Keratins | 1 | 2005 | 25 | 0.070 |
Why?
|
| Spermidine | 1 | 2005 | 31 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2009 | 486 | 0.070 |
Why?
|
| Mice | 4 | 2011 | 5668 | 0.070 |
Why?
|
| DNA, Complementary | 1 | 2005 | 175 | 0.070 |
Why?
|
| Endoplasmic Reticulum | 1 | 2005 | 101 | 0.060 |
Why?
|
| Glutathione | 1 | 2005 | 160 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 2005 | 455 | 0.060 |
Why?
|
| Immunoprecipitation | 2 | 2018 | 126 | 0.060 |
Why?
|
| Membrane Transport Proteins | 1 | 2024 | 88 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2009 | 71 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2005 | 360 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2005 | 490 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2024 | 193 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2005 | 562 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 600 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2023 | 252 | 0.050 |
Why?
|
| Heart | 1 | 2023 | 178 | 0.050 |
Why?
|
| Time Factors | 1 | 2005 | 1681 | 0.050 |
Why?
|
| Communicable Diseases | 1 | 2021 | 42 | 0.050 |
Why?
|
| Protein Interaction Mapping | 1 | 2018 | 57 | 0.040 |
Why?
|
| Cell Survival | 2 | 2011 | 818 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 255 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2011 | 1442 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2005 | 1802 | 0.040 |
Why?
|
| Histone Deacetylases | 2 | 2008 | 52 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 628 | 0.030 |
Why?
|
| gamma Catenin | 1 | 2012 | 1 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 2012 | 25 | 0.030 |
Why?
|
| Aptamers, Peptide | 1 | 2011 | 2 | 0.030 |
Why?
|
| Transcription Factors, TFIII | 1 | 2010 | 1 | 0.020 |
Why?
|
| Neoplasms | 1 | 2021 | 1033 | 0.020 |
Why?
|
| Metalloendopeptidases | 1 | 2010 | 15 | 0.020 |
Why?
|
| Receptor, PAR-1 | 1 | 2010 | 9 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 211 | 0.020 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2010 | 15 | 0.020 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2011 | 30 | 0.020 |
Why?
|
| Calpain | 1 | 2010 | 31 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2010 | 52 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2010 | 61 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2010 | 109 | 0.020 |
Why?
|
| Cell Death | 1 | 2011 | 260 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 247 | 0.020 |
Why?
|
| Claudins | 1 | 2009 | 8 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2009 | 30 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2010 | 209 | 0.020 |
Why?
|
| Histone Deacetylase 1 | 1 | 2008 | 14 | 0.020 |
Why?
|
| Phenotype | 1 | 2011 | 650 | 0.020 |
Why?
|
| Calcium | 1 | 2010 | 445 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2006 | 24 | 0.020 |
Why?
|
| Dimerization | 1 | 2005 | 102 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2010 | 1149 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 89 | 0.020 |
Why?
|
| Acetylation | 1 | 2005 | 94 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2005 | 149 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2005 | 168 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2005 | 257 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2005 | 350 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2005 | 154 | 0.020 |
Why?
|
| Transfection | 1 | 2005 | 496 | 0.010 |
Why?
|
| Histones | 1 | 2005 | 177 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 650 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 485 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 834 | 0.010 |
Why?
|
| DNA | 1 | 2005 | 549 | 0.010 |
Why?
|
| Phylogeny | 1 | 2005 | 612 | 0.010 |
Why?
|